Skip to content

Clinical trials

Phase 1 Leiomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 1 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20051
20061
20081
20121
20131
20193
20202
20221
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Baylor College of Medicine2
National Cancer Institute (NCI)2
Valerio Therapeutics2
Boundless Bio, Inc.1
Catherine Bollard1
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Eli Lilly and Company1
Epkin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma22
Sarcoma13
Histiocytoma, Malignant Fibrous10
Liposarcoma10
Sarcoma, Synovial7
Dermatofibrosarcoma5
Carcinoma, Non-Small-Cell Lung4
Chondrosarcoma4
Fibrosarcoma4
Hemangiosarcoma4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.